Olejniczak, US
Brian L. Olejniczak, Pleasanton, CA US
Patent application number | Description | Published |
---|---|---|
20110160709 | Apparatus and Processes for Preventing or Delaying One or More Symptoms of Presbyopia - The present invention generally relates to an apparatus and processes for preventing or delaying presbyopia. More particularly, the present invention relates to processes and apparatus for ablating epithelial cells in the germinative zone or the pregerminative zone of the crystalline lens of the eye so that onset or progression of presbyopia or one or more symptoms is delayed or prevented. | 06-30-2011 |
20140128854 | APPARATUS AND PROCESSES FOR PREVENTING OR DELAYING ONE OR MORE SYMPTOMS OF PRESBYOPIA - The present invention generally relates to an apparatus and processes for preventing or delaying presbyopia. More particularly, the present invention relates to processes and apparatus for ablating epithelial cells in the germinative zone or the pregerminative zone of the crystalline lens of the eye so that onset or progression of presbyopia or one or more symptoms is delayed or prevented. | 05-08-2014 |
Donna M. Olejniczak, Pittsburgh, PA US
Patent application number | Description | Published |
---|---|---|
20140341860 | Methods for treating cartilage disorders, diseases, and injuries - The invention is directed to methods for treating cartilage disorders, diseases and injuries including, but not limited to, degenerative disc disease. The invention is also directed to methods for preventing cartilage disorders and diseases including, but not limited to, degenerative disc disease. The field of the invention is further directed to reducing inflammation associated with cartilage disorders, diseases and injuries including, but not limited to, degenerative disc disease. | 11-20-2014 |
Edward Olejniczak, Grayslake, IL US
Patent application number | Description | Published |
---|---|---|
20110092445 | Amyloid peptide analogues, oligomers thereof, processes for preparing and composi-tions comprising said analogues or oligomers, and their uses - The present invention relates to an amyloid β peptide analogues comprising an amino acid sequence or a peptidomimetic thereof, wherein the sequence (i) forms a loop, (ii) has at least 66% identity to the amino acid sequence of native Aβ peptide or a portion thereof, (iii) comprises at least 6 contiguous amino acid residues and (iv) has at least 2 non-contiguous amino acid residues which are covalently linked with each other, oligomers comprising a plurality of said amyloid β peptide analogues, processes for preparing the amyloid β peptide analogues or oligomers, compositions comprising the amyloid β peptide analogues or oligomers, and uses of the amyloid β peptide analogues or oligomers such as their use for treating or preventing an amyloidosis (e.g. by active immunization), for diagnosing an amyloidosis, and for providing agents that are capable of binding to the amyloid β peptide analogues or oligomers. The subject invention also describes agents that are capable of binding to the amyloid β peptide analogues or oligomers, e.g. antibodies, compositions comprising the agents, and uses of the agents such as their use for treating or preventing an amyloidosis (e.g. by passive immunization) and for diagnosing an amyloidosis. | 04-21-2011 |
Edward T. Olejniczak, Nashville, TN US
Patent application number | Description | Published |
---|---|---|
20150336925 | SUBSTITUTED BENZOFURAN, BENZOTHIOPHENE AND INDOLE MCL-1 INHIBITORS - The present invention provides for compounds that inhibit the activity of an anti-apoptotic Bcl-2 family member Myeloid cell leukemia-1 (Mcl-1) protein. The present invention also provides for pharmaceutical compositions as well as methods for using compounds for treatment of diseases and conditions (e.g., cancer) characterized by the over-expression or dysregulation of Mcl-1 protein. | 11-26-2015 |
Edward T. Olejniczak, Grayslake, IL US
Patent application number | Description | Published |
---|---|---|
20090123946 | IMMUNOASSAYS AND KITS FOR THE DETECTION OF NGAL - The present invention relates to NGAL immunoassays and kits, and to methods of using glycosylated mammalian NGAL and antibodies that bind to mammalian NGAL in immunoassays and kits. Among other things, the methods and kits can be employed to determine the amount of human NGAL monomer in a test sample, as well as to determine the proportion of human NGAL monomer to human NGAL dimer contained in a test sample. | 05-14-2009 |
20090124022 | ANTIBODIES THAT BIND TO MAMMALIAN NGAL AND USES THEREOF - The present invention relates to antibodies specific for glycosylated mammalian NGAL, and to methods of making and using such antibodies. | 05-14-2009 |
20090214515 | METHODS OF PREPARATION OF RECOMBINANT FORMS OF HUMAN BETA-AMYLOID PROTEIN AND USES OF THESE PROTEINS - The subject invention relates to the cloning, expression and isolation of recombinant forms of beta-amyloid protein containing a N-terminal methionine (or one or more amino acids) as well as to methods of using this recombinant protein in the production of therapeutic antibodies, in the identification of therapeutic small molecules, and in the performance of diagnostic assays. | 08-27-2009 |
20090263894 | ANTIBODIES THAT BIND TO MAMMALIAN NGAL AND USES THEREOF - The present invention relates to antibodies specific for glycosylated mammalian NGAL, and to methods of making and using such antibodies. | 10-22-2009 |
20090269777 | IMMUNOASSAYS AND KITS FOR THE DETECTION OF NGAL - The present invention relates to NGAL immunoassays and kits, and to methods of using glycosylated mammalian NGAL and antibodies that bind to mammalian NGAL in immunoassays and kits. Among other things, the methods and kits can be employed to determine the amount of human NGAL monomer in a test sample, as well as to determine the proportion of human NGAL monomer to human NGAL dimer contained in a test sample. | 10-29-2009 |
20100227775 | IMMUNOASSAYS AND KITS FOR THE DETECTION OF NGAL - The present invention relates to NGAL immunoassays and kits, and to methods of using glycosylated mammalian NGAL and antibodies that bind to mammalian NGAL in immunoassays and kits. Among other things, the methods and kits can be employed to determine the amount of human NGAL monomer in a test sample, as well as to determine the proportion of human NGAL monomer to human NGAL dimer contained in a test sample. | 09-09-2010 |
Gregory B. Olejniczak, Carol Stream, IL US
Patent application number | Description | Published |
---|---|---|
20130286123 | SYSTEM AND METHOD FOR PRINTING ON A FLEXIBLE BODY - A printing system includes carriage assemblies, a preparation station, a printing station, and a selection station. The carriage assemblies receive flexible bodies and are coupled to a conveyance assembly that moves the carriage assemblies along a direction of travel. The preparation station receives the flexible bodies from the loading station and manipulates the flexible bodies to at least partially flatten printing surfaces of the flexible bodies. The printing station prints images on the flexible bodies. The selection station examines the images on the flexible bodies and selects one or more of the flexible bodies based on the images. The selection station also individually grips and removes selected flexible bodies from the carriage assemblies and conveys the selected flexible bodies to a first collection location while the other flexible bodies remain on the carriage assemblies and are conveyed to a different, second collection location. | 10-31-2013 |
20150158310 | SYSTEM AND METHOD FOR PRINTING ON A FLEXIBLE BODY - A printing system includes carriage assemblies, a preparation station, a printing station, and a selection station. The carriage assemblies receive flexible bodies and are coupled to a conveyance assembly that moves the carriage assemblies along a direction of travel. The preparation station receives the flexible bodies from the loading station and manipulates the flexible bodies to at least partially flatten printing surfaces of the flexible bodies. The printing station prints images on the flexible bodies. The selection station examines the images on the flexible bodies and selects one or more of the flexible bodies based on the images. The selection station also individually grips and removes selected flexible bodies from the carriage assemblies and conveys the selected flexible bodies to a first collection location while the other flexible bodies remain on the carriage assemblies and are conveyed to a different, second collection location. | 06-11-2015 |
Nicholas Jon Olejniczak, Madison, WI US
Patent application number | Description | Published |
---|---|---|
20100293034 | MULTI-VARIABLE PRODUCT RANK - Methods, systems, and computer-readable media for ranking products using multiple data sources are provided. A computerized ranking system includes a ranking engine, loaders, and a presentation component. The ranking engine calculates a score for each product based on multiple counts logged by data sources. Loaders communicatively connected to the ranking engine provide the counts to the data sources. The presentation component generates a ranked product list for display on client devices in response to requests for a list of popular products. | 11-18-2010 |
20120221442 | MULTI-VARIABLE PRODUCT RANK - Methods, systems, and computer-readable media for ranking products using multiple data sources are provided. A computerized ranking system includes a ranking engine, loaders, and a presentation component. The ranking engine calculates a score for each product based on multiple counts logged by data sources. Loaders communicatively connected to the ranking engine provide the counts to the data sources. The presentation component generates a ranked product list for display on client devices in response to requests for a list of popular products. | 08-30-2012 |
Ryan Olejniczak, Clinton Township, MI US
Patent application number | Description | Published |
---|---|---|
20160075272 | VEHICLE REMOTE START ATTEMPTS MESSAGING SYSTEM AND METHOD - In a messaging system, computer readable instructions are executable by a processor of a communications server to: detect a vehicle remote start attempt that is initiated by a mobile communications device, transmit a remote start request to the vehicle, and receive a notification corresponding to success and/or failure of the attempt. If the attempt fails, the computer readable instructions are executable by the processor to: receive a cause of the failure encoded in a dynamic error message, decode the dynamic error message, and construct a custom failure message that is indicative of the cause of the failure. If the attempt succeeds, the computer readable instructions are executable by the processor to generate a success message based upon the notification corresponding to the success of the attempt. The computer readable instructions are also executable by the processor to transmit the success or custom failure message to the mobile communications device. | 03-17-2016 |